Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

BBH vs FBDIX overlap: 40% of top holdings shared

Bottom line

How much do BBH and FBDIX overlap?

40% of their top holdings overlap by weight. 8 securities appear in both funds' top 25, making up 58.3% of BBH's assets and 26.0% of FBDIX's. They share a meaningful core but differ in the rest of the portfolio.

FBDIX holds far more positions (126 vs 25), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

BBHFBDIX
Weight overlap (top 25)40%
Shared holdings8
Weight in shared holdings58.3%26.0%
Total positions25126
Expense ratio0.35%1.01%
Holdings as ofJun 30, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Holdings BBH and FBDIX have in common

Holding% of BBH% of FBDIXOverlap
Amgen Inc15.25%4.39%4.39%
Gilead Sciences Inc12.79%3.86%3.86%
Vertex Pharmaceuticals Inc9.10%3.54%3.54%
Regeneron Pharmaceuticals Inc6.21%3.77%3.77%
Revolution Medicines Inc5.27%3.01%3.01%
Argenx SE4.97%3.62%3.62%
Insmed Inc2.67%1.99%1.99%
Neurocrine Biosciences Inc2.08%1.82%1.82%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in BBH

  1. Natera Inc — 4.92%
  2. IQVIA Holdings Inc — 4.31%
  3. Alnylam Pharmaceuticals Inc — 3.83%
  4. Biogen Inc — 3.63%
  5. Moderna Inc — 3.36%
  6. Illumina Inc — 3.17%
  7. United Therapeutics Corp — 2.83%
  8. BeOne Medicines Ltd — 2.81%
  9. Incyte Corp — 2.49%
  10. BioNTech SE — 1.94%
  11. Icon Plc — 1.90%
  12. Bio-Techne Corp — 1.54%
  13. Charles River Laboratories International Inc — 1.50%
  14. BioMarin Pharmaceutical Inc — 1.34%
  15. Qiagen Nv — 1.06%

Only in FBDIX

  1. Jazz Pharmaceuticals plc — 5.66%
  2. Franklin Institutional U.S. Government Money Market Fund — 3.18%
  3. Guardant Health, Inc. — 2.76%
  4. Ascendis Pharma A/S — 2.56%
  5. Dianthus Therapeutics, Inc. — 2.32%
  6. Mirum Pharmaceuticals, Inc. — 1.98%
  7. Praxis Precision Medicines, Inc. — 1.91%
  8. Spyre Therapeutics, Inc. — 1.87%
  9. Oruka Therapeutics, Inc. — 1.86%
  10. Bridgebio Pharma, Inc. — 1.67%
  11. PTC Therapeutics, Inc. — 1.65%
  12. AstraZeneca plc — 1.51%
  13. Franklin Institutional U.S. Government Money Market Fund — 1.45%
  14. Amylyx Pharmaceuticals, Inc. — 1.32%
  15. Eli Lilly & Co. — 1.31%

Asset mix

Asset typeBBHFBDIX
Stocks100.0%97.0%
Cash & short-term funds0.1%4.6%
Preferred stock—1.0%
Other—0.6%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Country mix

CountryBBHFBDIX
US87.3%82.0%
IE1.9%6.7%
NL6.0%4.5%
CH2.8%1.2%
DK—2.6%
DE1.9%0.8%
FR—1.7%
GB—1.5%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do BBH and FBDIX overlap?
About 40% by weight. 8 securities appear in both funds' top 25 holdings; they make up 58.3% of BBH's assets and 26.0% of FBDIX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do BBH and FBDIX have in common?
The largest shared holdings are Amgen Inc, Gilead Sciences Inc, Regeneron Pharmaceuticals Inc, Argenx SE, Vertex Pharmaceuticals Inc.
Should I own both BBH and FBDIX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, BBH or FBDIX?
FBDIX is broader, with 126 positions versus 25 for BBH. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.